ConductScience.org, home

Trial · NCT06956170

Adverse events270

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersBelantamab Mafodotin+Pomalidomide+Dexamethasone2102
otherAnaemiaBlood and lymphatic system disordersBortezomib + Pomalidomide + Dexamethasone2115
otherEosinophiliaBlood and lymphatic system disordersBelantamab Mafodotin+Pomalidomide+Dexamethasone0100
otherEosinophiliaBlood and lymphatic system disordersBortezomib + Pomalidomide + Dexamethasone1112
otherLeukocytosisBlood and lymphatic system disordersBelantamab Mafodotin+Pomalidomide+Dexamethasone0100
otherLeukocytosisBlood and lymphatic system disordersBortezomib + Pomalidomide + Dexamethasone1113
otherLeukopeniaBlood and lymphatic system disordersBelantamab Mafodotin+Pomalidomide+Dexamethasone0100
otherLeukopeniaBlood and lymphatic system disordersBortezomib + Pomalidomide + Dexamethasone2112
otherLymphopeniaBlood and lymphatic system disordersBelantamab Mafodotin+Pomalidomide+Dexamethasone0100
otherLymphopeniaBlood and lymphatic system disordersBortezomib + Pomalidomide + Dexamethasone1111
otherNeutropeniaBlood and lymphatic system disordersBelantamab Mafodotin+Pomalidomide+Dexamethasone1102
otherNeutropeniaBlood and lymphatic system disordersBortezomib + Pomalidomide + Dexamethasone1111
otherThrombocytopeniaBlood and lymphatic system disordersBelantamab Mafodotin+Pomalidomide+Dexamethasone3105
otherThrombocytopeniaBlood and lymphatic system disordersBortezomib + Pomalidomide + Dexamethasone41111
otherAtrial fibrillationCardiac disordersBelantamab Mafodotin+Pomalidomide+Dexamethasone0100
otherAtrial fibrillationCardiac disordersBortezomib + Pomalidomide + Dexamethasone1111
otherCataractEye disordersBelantamab Mafodotin+Pomalidomide+Dexamethasone3103
otherCataractEye disordersBortezomib + Pomalidomide + Dexamethasone1111
otherDry eyeEye disordersBelantamab Mafodotin+Pomalidomide+Dexamethasone2103
otherDry eyeEye disordersBortezomib + Pomalidomide + Dexamethasone1112

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06956170/events